A Randomized Controlled Trial of Menopausal Tool/App for Women

Conditions

• Menopausal Symptoms
• Menopause Symptom Management

Eligibility Criteria

Sex

ALL

Age

24 Years - 80 Years

Healthy Volunteers

Not accepted

Interventions

• EMMII — OTHER
  The tool/app, consists of educational components designed to enable women to more effectively identify menopause symptoms and feel confident in seeking treatment to address their symptoms. The tool/app also produces a tailored menopause discussion guide for patients to bring to their primary care appointment.
• Comparison Group — OTHER
  Receive educational menopause pamphlet describing menopause symptoms and evidence-based treatment options.

Study Details

The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its association with menopause-related health care utilization

Key Dates

Start date

May 7, 2025

Status verified

May 2025

Primary completion

May 15, 2027

Completion

Dec 15, 2027

Study Design

Enrollment

450 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: The tool/app, EMMII by BettrHealth
  EMMII by BettrHealth Technology consists of educational components designed to enable women to more effectively identify menopause symptoms and feel confident in seeking treatment to address their symptoms
• Experimental: Comparison Group/ Control Group
  Patients will receive the Mayo Clinic Patient Education Pamphlet MC5544 "Perimenopause \& Menopause".

Primary Outcome Measure

Frequency of app logins among intervention group. [ Time Frame: Up to 6 weeks ]

Locations (1)

Find similar trials in Rochester, MN